News
Alexion to present seven abstracts, including four oral presentations, from its leading rare neurology portfolio at EAN 2025: Cambridge, UK Monday, June 23, 2025, 13:00 Hrs [IST] ...
Amazon India offers at-home health diagnostics service with sample collection in under 60 minutes & lab results 6 hours across 6 cities: Our Bureau, Bengaluru Monday, June 23, 202 ...
Amsterdam, The Netherlands Monday, June 23, 2025, 12:00 Hrs [IST] ...
Nanoform secures €5 million R&D loan from Business Finland to advance clinical development of nanoapalutamide: Helsinki, Finland Monday, June 23, 2025, 11:00 Hrs [IST] Nanoform ...
UK MHRA approves Accord Healthcare’s anti-PD-1 monoclonal antibody, serplulimab to treat aggressive form of SCLC: United Kingdom Monday, June 23, 2025, 09:00 Hrs [IST] The Medic ...
Shardul Nautiyal, Mumbai Monday, June 23, 2025, 08:00 Hrs [IST] ...
Telangana IDMA eyes growth strategies of Gujarat & Maharashtra to replicate in local pharma sector: Peethaambaran Kunnathoor, Chennai. Monday, June 23, 2025, 08:00 Hrs [IST] Altho ...
Even though the Central government had revised the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) for the pharma industry last year, it remains toothless and statutorily unbinding, ...
FDI inflow into hospitals & diagnostic centres grew 4 per cent in FY25: Gireesh Babu, New Delhi Monday, June 23, 2025, 08:00 Hrs [IST] The Foreign Direct Investment (FDI) equity i ...
GRAIL announces positive top-line results from Galleri PATHFINDER 2 study: Menlo Park, California Saturday, June 21, 2025, 18:00 Hrs [IST] GRAIL, Inc, a healthcare company whose m ...
KARL STORZ US gets expanded indication for Solo+ Tympanostomy tube device to use in pediatric patients aged 6 to 24 months old: El Segundo, California Saturday, June 21, 2025, 17: ...
Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML: Houston Saturday, June 21, 2025, 15:00 Hrs [IST] Moleculin Biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results